menu
    • menu

    Company profile for Galderma

    NEW Drugs in Dev: 35
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of...
    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GaldermaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    World Trade Center, Avenue Gratta-Paille 2, 1018 Lausanne
    Telephone
    Telephone
    +41 21 642 78 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galderma-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galderma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galderma Shareholders Approve Annual Meeting Proposals
    Galderma Shareholders Approve Annual Meeting Proposals

    22 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7204234

    FIRSTWORD PHARMA
    22 Apr 2026
    Share Share
    Galderma Launches Alastin Regenerating Skin Nectar with TriHex+
    Galderma Launches Alastin Regenerating Skin Nectar with TriHex+

    16 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415545576/en/Galderma-Launches-New-Alastin-Regenerating-Skin-Nectar-with-TriHex-Powered-by-Its-Next-Generation-TriHex-Technology-Regenerative-Platform

    BUSINESSWIRE
    16 Apr 2026
    Share Share
    Sculptra, Restylane show promise in post-weight loss care
    Sculptra, Restylane show promise in post-weight loss care

    08 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260408331299/en/Interim-Data-From-Two-Ongoing-Investigator-initiated-Trials-Highlight-the-Role-of-Sculptra-and-Restylane-in-Addressing-Aesthetic-Changes-Associated-With-Weight-Loss-Medications-and-Menopause

    BUSINESSWIRE
    08 Apr 2026
    Share Share
    Nemolizumab Shows Benefit In Pediatric AD At AAD 2026
    Nemolizumab Shows Benefit In Pediatric AD At AAD 2026

    28 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260328320362/en/AAD-2026-Late-Breaking-Nemolizumab-Data-Demonstrate-Clinically-Meaningful-Benefits-for-Children-Aged-2-to-11-With-Moderate-to-Severe-Atopic-Dermatitis

    BUSINESSWIRE
    28 Mar 2026
    Share Share
    Galderma Highlights Skin Solutions Data At AAD 2026
    Galderma Highlights Skin Solutions Data At AAD 2026

    24 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260323553707/en/AAD-2026-Galderma-Showcases-Latest-Evidence-Supporting-Its-Full-Spectrum-Science-Driven-Solutions-for-Diverse-Skin-Needs

    BUSINESSWIRE
    24 Mar 2026
    Share Share
    Galderma Receives U.S. FDA Approval for Restylane Contour
    Galderma Receives U.S. FDA Approval for Restylane Contour

    23 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260322108467/en/Galderma-Receives-U.S.-FDA-Approval-for-Restylane-Contour-for-the-Correction-of-Temple-Hollowing

    BUSINESSWIRE
    23 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search